VOICED : Autorizan en China pruebas clinicas de dos nuevas vacunas contra el coronavirus

Chinese authorities have approved human trials for two experimental COVID-19 vaccines, developed by Sinovac-Botec and the Wuhan Institute. This brings the total to three vaccines in clinical trials in China. The first vaccine was approved on March 16, developed by the Academy of Military Sciences and CanSino. Phase 1 trials began on April 9, with recruitment for Phase 2 ongoing. Other Chinese projects using attenuated flu viruses or nucleic acids are in animal testing. Globally, pharmaceutical and research groups are racing to develop COVID-19 treatments and vaccines, with an effective vaccine expected to take 12 to 18 months.

Which two organizations developed the experimental COVID-19 vaccines approved for human trials in China?

• Sinovac-Botec and Wuhan Institute of Virology

• Pfizer and Moderna

• Johnson & Johnson and AstraZeneca

• BioNTech and Sinopharm

When did China approve the first tests for a COVID-19 vaccine developed by the Academy of Military Medical Sciences?

• February 20

• May 1

• March 16

• April 9

Which phase of clinical trials began on April 9 in China?

• Phase 1

• Phase 2

• Phase 3

• Phase 4

What is the estimated time frame for developing an effective COVID-19 vaccine?

• 3 to 6 months

• 24 to 36 months

• 12 to 18 months

• 6 to 9 months

What types of projects are being evaluated or tested on animals by Chinese teams?

• Projects using attenuated flu viruses or nucleic acids

• Projects using mRNA technology

• Projects using protein subunits

• Projects using live viruses